Mechanism of Microglial Recruitment in Alzheimer's Disease
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2002 - March 31, 2004
Grant ID
A2002217
Summary
The senile plaque, composed of aggregations of beta amyloid protein, is a pathological hallmark of Alzheimer’s disease. Accumulation of beta amyloid in the brain leads to the activation of microglia cells. Microglia cells are inflammatory cells that can produce substances that are toxic to neurons and lead to neuronal degeneration. Studies have shown that there are key steps for neuronal damage from the accumulation of microglia in senile plaques. First, the binding of microglia to beta amyloid occurs. Second, microglia are induced to produce chemoattractants that recruit additional microglia to the beta amyloid deposit. Finally, the production of neurotoxins from the recruited microglia cause cellular damage. Dr. El Khoury is studying the mechanisms of the recruitment of microglia to senile plaques in AD using an in vitro cellular model for microglia interactions, post-mortem human brain tissue from AD patients and transgenic mice. He plans to identify chemoattractants produced by microglia and the receptors that are involved, the expression of the chemoattractants and their receptors in brain tissue and in mouse models of AD, and the effects of disrupting the expression of chemoattractants and the receptors in the recruitment of microglia. Understanding the mechanisms of recruitment of microglia to plaques and how they become activated to produce neurotoxins may help to identify new targets for the development of treatments for AD.
Related Grants
Alzheimer's Disease Research
Understanding the Role of Brain Immune Cells in Protection Against Alzheimer’s
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Ghazaleh Eskandari-Sedighi, PhD
Current Organization
University of California, Irvine
Understanding the Role of Brain Immune Cells in Protection Against Alzheimer’s
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Ghazaleh Eskandari-Sedighi, PhD
Current Organization
University of California, Irvine
Alzheimer's Disease Research
Leveraging How the Brain’s Immune Cells Fuel Frontotemporal Dementia
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Laura Fumagalli, PhD
Current Organization
Flanders Institute for Biotechnology
Leveraging How the Brain’s Immune Cells Fuel Frontotemporal Dementia
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Laura Fumagalli, PhD
Current Organization
Flanders Institute for Biotechnology
Alzheimer's Disease Research
Blocking Jumping Genes to Stop Brain Inflammation in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Joseph Herdy, PhD
Current Organization
The Salk Institute for Biological Studies
Blocking Jumping Genes to Stop Brain Inflammation in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Joseph Herdy, PhD
Current Organization
The Salk Institute for Biological Studies